WAKE FOREST UNIVERSITY HEALTH SCIENCES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Phase I Trial of Inhaled Nitric Oxide to Treat Acute Pulmonary Embolism

Phase 1

Completed

Conditions: Pulmonary Embolism

Interventions: Drug: nitric oxide

First Posted Date: 2009-02-20

Last Posted Date: 2022-04-25

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 25

Registration Number: NCT00848731

Locations: 🇺🇸
Carolinas Medical Center, Charlotte, North Carolina, United States

Early Versus Late Bronchoscopy in Bone Marrow Transplantation (BMT) Patients

Not Applicable

Completed

Conditions: Bone Marrow Transplantation

Interventions: Procedure: Variation in the time for performing bronchoscopy

First Posted Date: 2009-02-18

Last Posted Date: 2017-04-20

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 22

Registration Number: NCT00846352

Locations: 🇺🇸
Wake Forest University Baptist Medical Center, Winston-Salem, North Carolina, United States
🇺🇸
The Ohio State University Medical Center, Columbus, Ohio, United States
🇺🇸
The University of Mississippi Medical Center, Jackson, Mississippi, United States

Rapid Administration of Insulin in Sepsis

Phase 1

Completed

Conditions: Septic Shock

Interventions: Drug: GIK

First Posted Date: 2009-01-15

Last Posted Date: 2022-04-25

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 20

Registration Number: NCT00823108

Locations: 🇺🇸
Carolinas Medical Center, Charlotte, North Carolina, United States

C-11 Choline PET-CT Scan in Finding Metastases in Patients With Newly Diagnosed High-Risk Prostate Cancer

Phase 1

Completed

Conditions: Prostate Cancer

Interventions: Procedure: needle biopsy
Drug: PET-CT scans supplemented with 11C-Choline tracer

First Posted Date: 2008-12-08

Last Posted Date: 2018-07-03

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 18

Registration Number: NCT00804245

Locations: 🇺🇸
Wake Forest University Comprehensive Cancer Center, Winston-Salem, North Carolina, United States

Amantadine and Temporal Discrimination in Patients With Traumatic Brain Injury (TBI)

Not Applicable

Withdrawn

Conditions: Traumatic Brain Injury

Interventions: Drug: amantadine

First Posted Date: 2008-12-02

Last Posted Date: 2022-04-27

Lead Sponsor: Wake Forest University Health Sciences

Registration Number: NCT00800514

Locations: 🇺🇸
CHS-Behavioral Health Research, Charlotte, North Carolina, United States

Amantadine for the Treatment of Traumatic Brain Injury Irritability and Aggression: A Multi-site Study

Not Applicable

Completed

Conditions: Aggression
Brain Injury

Interventions: Drug: Placebo
Drug: Amantadine Hydrochloride

First Posted Date: 2008-10-24

Last Posted Date: 2022-07-12

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 168

Registration Number: NCT00779324

Locations: 🇺🇸
Indiana University and the Rehabilitation Hospital of Indiana, Indianapolis, Indiana, United States
🇺🇸
Carolinas Rehabilitation, Charlotte, North Carolina, United States
🇺🇸
The Ohio State University, Columbus, Ohio, United States

and more 3 locations

Phentermine/Gastric Band Weight Loss Study

Not Applicable

Withdrawn

Conditions: Obesity

Interventions: Other: Placebo
Drug: Phentermine

First Posted Date: 2008-10-13

Last Posted Date: 2022-04-21

Lead Sponsor: Wake Forest University Health Sciences

Registration Number: NCT00771654

Studying Urine and Blood Samples in Women With Newly Diagnosed Breast Cancer

Completed

Conditions: Breast Cancer

First Posted Date: 2008-10-06

Last Posted Date: 2017-08-01

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 1104

Registration Number: NCT00766454

Locations: 🇺🇸
Wake Forest University Comprehensive Cancer Center, Winston-Salem, North Carolina, United States

Comparison of Dobutamine and Regadenoson Stress Cardiac Magnetic Resonance (MR)

Early Phase 1

Terminated

Conditions: Coronary Artery Disease
Asthma
Chronic Obstructive Pulmonary Disease (COPD)
Angina

Interventions: Drug: Regadenoson
Drug: Dobutamine

First Posted Date: 2008-09-30

Last Posted Date: 2018-09-26

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 14

Registration Number: NCT00763035

Locations: 🇺🇸
WAKE FOREST UNIVERSITY Baptist Medical Center, Winston-Salem, North Carolina, United States

American Ginseng Extract in Preventing Respiratory Infection and in Reducing Antibiotic Use in Patients With CLL

Phase 2

Completed

Conditions: Leukemia

Interventions: Dietary Supplement: American ginseng
Dietary Supplement: Placebo

First Posted Date: 2008-09-16

Last Posted Date: 2021-09-28

Lead Sponsor: Wake Forest University Health Sciences

Target Recruit Count: 293

Registration Number: NCT00752895

Locations: 🇺🇸
Providence Saint Joseph Medical Center - Burbank, Burbank, California, United States
🇺🇸
Memorial Hospital, Carthage, Illinois, United States
🇺🇸
Galesburg Clinic, PC, Galesburg, Illinois, United States

and more 122 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy